145 related articles for article (PubMed ID: 37375979)
21. Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts by indole-3-carbinol: dose-response studies in the rat colon.
Xu M; Schut HA; Bjeldanes LF; Williams DE; Bailey GS; Dashwood RH
Carcinogenesis; 1997 Nov; 18(11):2149-53. PubMed ID: 9395215
[TBL] [Abstract][Full Text] [Related]
22. Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals.
Iwata H; Yamaguchi K; Takeshita Y; Kubota A; Hirakawa S; Isobe T; Hirano M; Kim EY
Aquat Toxicol; 2015 May; 162():138-151. PubMed ID: 25814058
[TBL] [Abstract][Full Text] [Related]
23. Role of human sulfotransferase 1A1 and N-acetyltransferase 2 in the metabolic activation of 16 heterocyclic amines and related heterocyclics to genotoxicants in recombinant V79 cells.
Chevereau M; Glatt H; Zalko D; Cravedi JP; Audebert M
Arch Toxicol; 2017 Sep; 91(9):3175-3184. PubMed ID: 28160022
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of drug metabolizing enzymes (cytochrome P450) in vitro as well as in vivo by Phyllanthus amarus SCHUM & THONN.
Hari Kumar KB; Kuttan R
Biol Pharm Bull; 2006 Jul; 29(7):1310-3. PubMed ID: 16819159
[TBL] [Abstract][Full Text] [Related]
25. In vitro inhibition of liver monooxygenases by beta-ionone, 1,8-cineole, (-)-menthol and terpineol.
De-Oliveira AC; Fidalgo-Neto AA; Paumgartten FJ
Toxicology; 1999 Jul; 135(1):33-41. PubMed ID: 10454222
[TBL] [Abstract][Full Text] [Related]
26. EROD and MROD as Markers of Cytochrome P450 1A Activities in Hepatic Microsomes from Entire and Castrated Male Pigs.
Zamaratskaia G; Zlabek V
Sensors (Basel); 2009; 9(3):2134-47. PubMed ID: 22574004
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the concentration-effect relationships of PAHs on CYP1A induction in HepG2 and Mcf7 cells.
Skupinska K; Misiewicz I; Kasprzycka-Guttman T
Arch Toxicol; 2007 Mar; 81(3):183-200. PubMed ID: 16953391
[TBL] [Abstract][Full Text] [Related]
28. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
Yao HT; Chang YW; Lan SJ; Yeh TK
Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of butylated hydroxytoluene chemoprevention of aflatoxicosis--inhibition of aflatoxin B1 metabolism.
Guarisco JA; Hall JO; Coulombe RA
Toxicol Appl Pharmacol; 2008 Mar; 227(3):339-46. PubMed ID: 18177683
[TBL] [Abstract][Full Text] [Related]
30. The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line.
Avery ML; Meek CE; Audus KL
Placenta; 2003 Jan; 24(1):45-52. PubMed ID: 12495659
[TBL] [Abstract][Full Text] [Related]
31. Structure characteristics of flavonoids for heterocyclic aromatic amines inhibition using quantitative structure-activity relationship modeling.
Zhao L; Pan F; Li Y; Hao S; Mehmood A; Wang Y; Wang C
J Food Biochem; 2020 Sep; 44(9):e13390. PubMed ID: 32710583
[TBL] [Abstract][Full Text] [Related]
32. Effect of sulfur dioxide inhalation on CYP1A1 and CYP1A2 in rat liver and lung.
Qin G; Meng Z
Toxicol Lett; 2005 Dec; 160(1):34-42. PubMed ID: 16023800
[TBL] [Abstract][Full Text] [Related]
33. Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2.
Tsyrlov IB; Goldfarb IS; Gelboin HV
Arch Biochem Biophys; 1993 Dec; 307(2):259-66. PubMed ID: 8274012
[TBL] [Abstract][Full Text] [Related]
34. Cytochrome P450 Enzyme Inhibition and Herb-Drug Interaction Potential of Medicinal Plant Extracts Used for Management of Diabetes in Nigeria.
Amaeze O; Eng H; Horlbogen L; Varma MVS; Slitt A
Eur J Drug Metab Pharmacokinet; 2021 May; 46(3):437-450. PubMed ID: 33844145
[TBL] [Abstract][Full Text] [Related]
35. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
36. Modulation by phytochemicals of cytochrome P450-linked enzyme activity.
Teel RW; Huynh H
Cancer Lett; 1998 Nov; 133(2):135-41. PubMed ID: 10072162
[TBL] [Abstract][Full Text] [Related]
37. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.
Takahashi N; Harttig U; Williams DE; Bailey GS
Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141
[TBL] [Abstract][Full Text] [Related]
38. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
[TBL] [Abstract][Full Text] [Related]
39. Potent and Selective Inhibition of CYP1A2 Enzyme by Obtusifolin and Its Chemopreventive Effects.
Park EJ; Park K; Durai P; Kim KY; Park SY; Kwon J; Lee HJ; Pan CH; Liu KH
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559174
[TBL] [Abstract][Full Text] [Related]
40. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.
Chang TK; Chen J; Benetton SA
Drug Metab Dispos; 2002 Apr; 30(4):378-84. PubMed ID: 11901090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
